Loading organizations...
The Cancer Prevention and Research Institute of Texas (CPRIT) is a state agency funding cancer research, prevention, and product development within Texas. It invests in academic and biotechnology projects, translating discoveries into clinical applications and public health initiatives. CPRIT fosters innovation to reduce the statewide cancer burden.
CPRIT was established in 2007 by public vote, reflecting Texans' commitment to combating cancer. The insight: substantial state investment was crucial to position Texas as a leader in cancer research and prevention. This mandate led to an initial $3 billion allocation, financed via state bonds, creating the largest state-funded cancer research endeavor in U.S. history.
The institute supports researchers in Texas academic institutions and companies developing cancer-related products. CPRIT’s mission is to improve Texans' health outcomes by accelerating scientific advancements and ensuring access to evidence-based prevention strategies. It envisions a future with diminished cancer incidence and mortality throughout the state.
Key people at Cancer Prevention and Research Institute of Texas.
Cancer Prevention and Research Institute of Texas has 7 tracked investments across 6 companies. The latest tracked deal is $15.0M Grant in CrossBridge Bio in November 2025.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Nov 20, 2025 | CrossBridge Bio | $15.0M Grant | Cancer Prevention And Research Institute OF Texas | — |
| Aug 20, 2022 | Emtora Biosciences | $16.9M Grant | Cancer Prevention And Research Institute OF Texas | — |
| Aug 26, 2019 | Emtora Biosciences | $3.0M Seed | Cancer Prevention And Research Institute OF Texas | — |
| Aug 24, 2018 | Forbius | $18.8M Grant | Cancer Prevention And Research Institute OF Texas | — |
| Aug 21, 2017 | AlloVir | $9.0M Grant | Cancer Prevention And Research Institute OF Texas | — |
| Feb 24, 2014 | DNAtriX | $10.8M Grant | Cancer Prevention And Research Institute OF Texas | — |
| Jul 23, 2012 | Kuur Therapeutics | $26.4M Other Equity | — | Imperial Innovations, Invesco Perpetual |
Key people at Cancer Prevention and Research Institute of Texas.